Author:
Sorich Michael J.,Wiese Michael D.,O’Shea Rebekah L.,Pekarsky Brita
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference87 articles.
1. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004;44(3):720–32.
2. National Center for Health Statistics. Health, United States, 2010: with special feature on death and dying [DHHS Publication No. 2011-1232]. Hyattsville: US Department of Health and Human Services; 2011.
3. Department of Health and Ageing. Pharmaceutical Benefits Scheme (PBS): expenditure and prescriptions twelve months to 30 June 2011. Canberra: Australian Government. 2012. http://www.health.gov.au/internet/main/publishing.nsf/content/pbs-stats-pbexp-jun11 . Accessed 19 Aug 2012.
4. Aitken M, Berndt ER, Cutler DM. Prescription drug spending trends in the United States: looking beyond the turning point. Health Aff. 2009;28(1):w151–60.
5. Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32(14):1769–818.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献